Skip to content
soligenix-logo
Soligenix
Main Menu
About
Show submenu
Corporate Overview
Board of Directors
Executive Team
Scientific Advisory Boards
Show submenu
Cutaneous T-Cell Lumphoma
Oral Mucositis
Pediatric Crohn’s Disease
Radiation Enteritis
Acute Radiation Syndrome
Careers
Show submenu
Working at Soligenix
Job Openings
Contact
Careers
Pipeline + Programs
Show submenu
Pipeline
Specialized BioTherapeutics
Show submenu
SGX301 for Cutaneous T-Cell Lymphoma (CTCL)
SGX942 for Oral Mucositis
SGX203 for Pediatric Crohn’s Disease
SGX201 for Radiation Enteritis
Public Health Solutions
Show submenu
RiVax
®
to Prevent Ricin Poisoning
SGX943 for Infectious Disease
ThermoVax
®
: Thermostabilized Vaccines for Global Use
Reference Literature
Show submenu
Specialized BioTherapeutics
Public Health Solutions
Relevant Publications
Clinical Trials
Our Focus
Show submenu
Specialized BioTherapeutics
Show submenu
Cutaneous T-Cell Lymphoma
Pediatric Crohn’s Disease
Oral Mucositis
Radiation Enteritis
Public Health Solutions
Show submenu
Thermal Stabilization of Vaccines
Ricin Exposure
GI Acute Radiation Syndrome
Melioidosis
Partnering
Investors
Show submenu
Investor Overview
News Releases
SEC Filings
Corporate Governance
Stock Information
Analyst Coverage
Investor Alerts
Investor Alerts
Enter the email address that you used to subscribe to this list.
Email
